Opinion · 29 Apr 2026
Conference abstractPublished 4 Jul 2019
Good reporting practices
Educe Solutions, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The process of informing adverse drug reaction to the regulatory authorities or too concerned persons is known as reporting. It is mandated by drug regulatory authorities for a marketing authorization holder to report adverse event reports. Different countries have their reporting rules. The case reports should include information on adverse event, suspected and concomitant product therapy details, patient details, clinical course and outcomes, narrative, dechallenge and rechallenge information, company comments etc. The events should be coded with the most recent version of MedDRA used at the lowest level term (LLT) and in line with the latest points to consider document. The follow up information received after the submission of initial version of the case should also be reported to the regulatory authorities depending upon medical significance of the information received. Significant follow up would require reporting to the authority whereas non-significant follow up information would not. Care should be taken for the multiple cases reported in a single report e.g., multiple cases available in a single publication, mother baby case report. These reports should be linked. Upon completion of data entry in a case report, the case can be either reported as a paper format (CIOMS-I) or electronically (E2B). Case series should be developed and evaluated by the MAHs for any signal or safety information. Different parameters to considered for case evaluation are Temporal relationship, causality assessment, other confounding factors etc. On the basis of evaluation, a safety issue should be communicated to the regulatory authority as well as general public.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 12 Mar 2026
Principles and Implementation of Good Pharmacovigilance Practice in Modern Drug Safety Systems
Commentary · 16 Jan 2025
Good Manufacturing Practices among Small and Medium Enterprises in Pharmacy
Commentary · 30 Dec 2024
The Role of Good Manufacturing Practices (GMP) in Pharmaceutical Quality Control
Perspective · 8 Dec 2023
The Role of Good Distribution Practice in Pharmaceutical Supply Chains
More from this journal
The newest in Journal of Formulation Science & Bioavailability.
Opinion · 29 Nov 2025
AI Revolutionizing Pharmaceutical Formulation: Efficiency, Safety, Innovation
Opinion · 29 Nov 2025
Advanced Nanodrug Delivery for Poorly Soluble Drugs
Commentary · 29 Nov 2025
Oral Biopharmaceutical Delivery: Advanced Formulation Solutions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Formulation Science & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Samiksha Gupta”

